Press-release for stocks in the mining, quarrying, and oil and gas extraction sector

Prices are updated after-hours

sector : Mining, quarrying, and oil and gas extraction source : Www.biospace.com

save search

Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives-Adenosine clinical development paused
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
PRTG | $0.2972 9.67% 10.71% 410K

Mining, Quarrying, and Oil and ...

| -40.0% | O: -2.0% H: 4.08% C: -7.14%
biotech

XORTX Announces New Clinical Advisory Board Member - March 27, 2024
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 77

Health Technology

| -7.26% | O: -0.26% H: 0.0% C: 0.0%
XRTX | News | $2.88 -3.36% -2.41% 23K

Mining, Quarrying, and Oil and ...

| -23.95% | O: 0.0% H: 0.0% C: -5.79%
SNY | News | $47.15 1.84% 1.75% 2M

Health Technology

| -5.95% | O: 1.06% H: 0.0% C: 0.0%

Cannabis Bioscience International Holdings, Inc. Announces Engagement of Bull in Advantage as its Investor Relations Firm
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
CBIH | $0.0006 -62.5% 600K

Mining, Quarrying, and Oil and ...

| 0.0% | O: 0.0% H: 33.33% C: 16.67%
cannabis advantage bioscience international

Portage Biotech to Participate in Citi's 2023 Virtual Oncology Leadership Summit
Published: 2023-02-15 (Crawled : 16:00) - biospace.com/
PRTG | $0.2972 9.67% 10.71% 410K

Mining, Quarrying, and Oil and ...

| -92.96% | O: 0.0% H: 5.28% C: -0.94%
biotech

XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical TrialSafe and Effective Dosing of XORLO™
Published: 2023-01-19 (Crawled : 13:00) - biospace.com/
XRTX | News | $2.88 -3.36% -2.41% 23K

Mining, Quarrying, and Oil and ...

| 269.19% | O: 37.97% H: 14.81% C: -19.44%
oxy-101 topline positive results

XORTX Announces Completion of Dosing in XRX-OXY-101 Clinical Study
Published: 2022-12-19 (Crawled : 13:00) - biospace.com/
XRTX | News | $2.88 -3.36% -2.41% 23K

Mining, Quarrying, and Oil and ...

| 254.82% | O: 0.68% H: 3.52% C: -7.3%
oxy-101 study

XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)Independent Study Shows Moderate Dose Strength of XORLO™ Attenuates Kidney Expansion
Published: 2022-12-08 (Crawled : 13:20) - biospace.com/
XRTX | News | $2.88 -3.36% -2.41% 23K

Mining, Quarrying, and Oil and ...

| 228.37% | O: 0.0% H: 0.0% C: -2.86%
expansion disease kidney study

UroGen Announces New Data from the OLYMPUS Trial that Shows Median Durability of Response of 28.9 Months for JELMYTO®, the Only Non-Surgical, Chemoablative Treatment for Adults with Low-Grade Upper Tra...
Published: 2022-12-02 (Crawled : 13:00) - biospace.com/
WDH | $1.19 -2.46% 0.0% 480K

Finance and Insurance

| -26.54% | O: -3.09% H: 6.37% C: 2.55%
VNDA | $4.8 -6.07% -6.46% 1.9M

Health Technology

| -53.88% | O: -0.55% H: 0.64% C: 0.09%
URGN | $14.37 4.66% 4.45% 280K

Health Technology

| 64.6% | O: -1.49% H: 3.84% C: -2.44%
SNDX | $20.96 0.77% 0.81% 670K

Health Technology

| -16.26% | O: -0.16% H: 1.12% C: 0.32%
GTHX | $4.1 -0.24% -0.24% 470K

Health Technology

| -29.91% | O: -2.22% H: 9.27% C: 7.69%
ACET | News | $2.0 2.56% 2.5% 260K

Health Technology

| -89.24% | O: -1.13% H: 5.01% C: 4.84%
jelmyto treatment trial response

XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics StudyXRX-OXY-101 Study will inform the dose choice in the upcoming Phase 3 Clinical Trial
Published: 2022-11-28 (Crawled : 13:00) - biospace.com/
XRTX | News | $2.88 -3.36% -2.41% 23K

Mining, Quarrying, and Oil and ...

| 200.1% | O: 0.73% H: 6.19% C: -3.08%
oxy-101 trial study

Ginkgo Bioworks Completes Acquisition of Zymergen
Published: 2022-10-19 (Crawled : 14:00) - biospace.com/
ZY | $2.43 0.0%

Mining, Quarrying, and Oil and ...

| Email alert Add to watchlist
acquisition

XORTX Completes Positive Pre-Phase 3 Meeting with the US Food and Drug Administration
Published: 2022-09-19 (Crawled : 12:00) - biospace.com/
XRTX | News | $2.88 -3.36% -2.41% 23K

Mining, Quarrying, and Oil and ...

| 125.78% | O: 1.69% H: 2.95% C: -8.57%
drug meeting food positive

Portage Biotech Announces Results for Fiscal Quarter Ended June 30, 2022
Published: 2022-08-29 (Crawled : 17:00) - biospace.com/
PRTG | $0.2972 9.67% 10.71% 410K

Mining, Quarrying, and Oil and ...

| -96.33% | O: -6.97% H: 12.75% C: 4.47%
biotech

XORTX Announces Positive Topline Results from Part 2 Pharmacokinetics Bridging Study
Published: 2022-08-22 (Crawled : 12:20) - biospace.com/
XRTX | News | $2.88 -3.36% -2.41% 23K

Mining, Quarrying, and Oil and ...

| 91.39% | O: 23.18% H: 4.3% C: -11.29%
topline positive results study

Portage Biotech Announces Results for Fiscal Year Ended March 31, 2022
Published: 2022-08-01 (Crawled : 14:00) - biospace.com/
PRTG | $0.2972 9.67% 10.71% 410K

Mining, Quarrying, and Oil and ...